These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25914370)

  • 21. High-throughput process development: I. Process chromatography.
    Rathore AS; Bhambure R
    Methods Mol Biol; 2014; 1129():29-37. PubMed ID: 24648064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applying high-throughput methods to develop a purification process for a highly glycosylated protein.
    Sanaie N; Cecchini D; Pieracci J
    Biotechnol J; 2012 Oct; 7(10):1242-55. PubMed ID: 22899660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miniaturized parallel screens to identify chromatographic steps required for recombinant protein purification.
    Rege K; Heng M
    Nat Protoc; 2010 Mar; 5(3):408-17. PubMed ID: 20203660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high-throughput approach to developing and optimizing mixed-mode membrane chromatography for protein purification.
    McKechnie WS; Thom V; Kupracz L; Pollard J; Kandula S; Welsh J
    Biotechnol Prog; 2023 Mar; 39(2):e3308. PubMed ID: 36300814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High throughput process development workflow with advanced decision-support for antibody purification.
    Stamatis C; Goldrick S; Gruber D; Turner R; Titchener-Hooker NJ; Farid SS
    J Chromatogr A; 2019 Jul; 1596():104-116. PubMed ID: 30885400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
    Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
    J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative high throughput analytics to support polysaccharide production process development.
    Noyes A; Godavarti R; Titchener-Hooker N; Coffman J; Mukhopadhyay T
    Vaccine; 2014 May; 32(24):2819-28. PubMed ID: 24576849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique selectivity windows using selective displacers/eluents and mobile phase modifiers on hydroxyapatite.
    Morrison CJ; Gagnon P; Cramer SM
    J Chromatogr A; 2010 Oct; 1217(42):6484-95. PubMed ID: 20832806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meeting report: High-throughput process development--HTPD 2012: June 4-7, 2012, Avignon, France.
    Hansen SK; Oelmeier SA
    Biotechnol J; 2012 Oct; 7(10):1189-91. PubMed ID: 23042625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization-based framework for resin selection strategies in biopharmaceutical purification process development.
    Liu S; Gerontas S; Gruber D; Turner R; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2017 Jul; 33(4):1116-1126. PubMed ID: 28393478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A versatile noninvasive method for adsorber quantification in batch and column chromatography based on the ionic capacity.
    Huuk TC; Briskot T; Hahn T; Hubbuch J
    Biotechnol Prog; 2016 May; 32(3):666-77. PubMed ID: 27324662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput isotherm determination and thermodynamic modeling of protein adsorption on mixed mode adsorbents.
    Nfor BK; Noverraz M; Chilamkurthi S; Verhaert PD; van der Wielen LA; Ottens M
    J Chromatogr A; 2010 Oct; 1217(44):6829-50. PubMed ID: 20880532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput screening of chromatographic separations: II. Hydrophobic interaction.
    Kramarczyk JF; Kelley BD; Coffman JL
    Biotechnol Bioeng; 2008 Jul; 100(4):707-20. PubMed ID: 18496875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purifying biopharmaceuticals: knowledge-based chromatographic process development.
    Hanke AT; Ottens M
    Trends Biotechnol; 2014 Apr; 32(4):210-20. PubMed ID: 24630477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A strategy for clone selection under different production conditions.
    Legmann R; Benoit B; Fedechko RW; Deppeler CL; Srinivasan S; Robins RH; McCormick EL; Ferrick DA; Rodgers ST; Russo AP
    Biotechnol Prog; 2011; 27(3):757-65. PubMed ID: 21448991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Throughput Process Development: I-Process Chromatography.
    Rathore AS; Bhambure R
    Methods Mol Biol; 2021; 2178():11-20. PubMed ID: 33128739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatographic techniques in the downstream processing of proteins in biotechnology.
    Freitag R
    Methods Mol Biol; 2014; 1104():419-58. PubMed ID: 24297429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization and automation of an end-to-end high throughput microscale transient protein production process.
    Bos AB; Luan P; Duque JN; Reilly D; Harms PD; Wong AW
    Biotechnol Bioeng; 2015 Sep; 112(9):1832-42. PubMed ID: 25851051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing new monoclonal antibody purification processes using mixed-mode chromatography sorbents.
    Toueille M; Uzel A; Depoisier JF; Gantier R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):836-43. PubMed ID: 21439915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput screening of chromatographic separations: IV. Ion-exchange.
    Kelley BD; Switzer M; Bastek P; Kramarczyk JF; Molnar K; Yu T; Coffman J
    Biotechnol Bioeng; 2008 Aug; 100(5):950-63. PubMed ID: 18551530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.